Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 06, 2025 22:50 ET | Source: Amaran Biotech

Amaran Biotech Signs MOU with Nippon Fine Chemical

Amaran Biotechnology Inc., a subsidiary of OBI Pharma specializing in Contract Development and Manufacturing Organization (CDMO) services for next-generati
November 19, 2024 05:27 ET | Source: Ardena Holding NV.

Ardena’s New State-of-the-Art Nanomedicine Facility Secures Full GMP Approval for Manufacturing

Ardena’s Oss facility secures GMP approval for nanomedicine manufacturing, enhancing capabilities in innovative drug development.
February 02, 2023 10:00 ET | Source: Roots Analysis

Liposome development and liposome manufacturing services market is anticipated to grow at a CAGR of nearly 10% till 2035, claims Roots Analysis

London, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Liposome Development and Liposome Manufacturing Services Market, 2022-2035” report to its list of offerings. ...
October 05, 2021 11:00 ET | Source: The Insight Partners

Ocular Drug Delivery Market Size to Outstrip $27,016.20Mn by 2028 Growth Projections at 7.4% CAGR During 2021 to 2028 COVID Impact and Global Analysis by TheInsightPartners.com

New York, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Ocular Drug Delivery Market: Key InsightsAccording to our new research study on "Ocular Drug Delivery Market to 2028 – Global Analysis and Forecast – by...
May 18, 2017 09:00 ET | Source: Plandai Biotechnology, Inc.

Plandaí Biotechnology's Upcoming Clinical Trial Could Strengthen Case for Phytofare in Treatment of Diabetes

NEW YORK, NY--(Marketwired - May 18, 2017) - Plandaí Biotechnology (OTCQB: PLPL) announced that it will conduct a human clinical trial to study the effectiveness of using its highly bioavailable...
May 10, 2017 09:00 ET | Source: Plandai Biotechnology, Inc.

Plandaí Biotechnology Changing the Future of Green Tea with Technology Used in Origine 8 Capsules

NEW YORK, NY--(Marketwired - May 10, 2017) - Plandaí Biotechnology's (OTCQB: PLPL) Origine 8™ capsules could be the future of green tea. Drinking a cup of green tea tastes great, but unless the eight...